ArticleNature communications2024

Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis.

Haressh Sajiir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.